ESR1 and breast cancer: Studies showed that majority of screen-detected breast cancers (SBCs) were small in size, node-negative, of early stages and positive for estrogen receptor (ER) and progesterone receptor (PR) (Bellio et al. 2017; Johnson et al. 2019).